“…Importantly, since the extracted trace amounts of ISF are diluted by a large amount of isolate, often only high concentrations of biomarkers in the ISF can be sensed; (2) “on-the-patch” sensing, which involves in situ detection of the patch on the skin or isolated detection after the patch is removed from the skin. Both detection ways have the advantage of directly sensing biomarkers captured on MNs without any separation process. , Apparently, the “on-the-patch” sensing strategy is more promising. But the most reported MNs are electrochemical sensors ,, or serval immunoassay-related patches, ,, which are not sufficient to meet the current needs of ISF diagnostics owing to their limitations in low sensitivity, poor stability, strong interference in vivo detection, etc.…”